Topic
Generic Drugs
171 published works
The State AG Report
Connecticut AG Tong Seeks Approval of Settlements with Three Generic Drug Manufacturers in Antitrust Case
The post Connecticut AG Tong Seeks Approval of Settlements with Three Generic Drug Manufacturers in Antitrust Case appeared first on The State AG Report.
Drug & Device Law
Interesting Law Review Article Describes Innovator Liability as “Market Shift” Liability
By Bexis
The recent law review article by the always interesting and extremely prolific Lars Noah, “‘Market Shift Liability’ for Generic Drugs: Market Share Theory’s Eccentric New Cousin,” 13 Tex. A&M L.…
Spicy IP
Bearing the Burdens of Bolar
By SpicyIP
The Madras High Court’s decision in Novartis AG v. Venkata Narayana Active Ingredients offers the first post-trial examination of the evidence required to invoke Section 107A for exports to get…
Patent Law Weblog
Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs – Part II
By Kevin E. Noonan – In recent years, the Federal Circuit has, with varying levels of agreement, considered what behavior by generic drugmakers constitutes inducement of infringement regarding so-called “off-label”…
Spicy IP
‘Venetoclax’ at the IPO: Why Generics Need More than Patent Refusals
How much of a win is a patent rejection for domestic generics production? In this post, I discuss the specific points of IPO’s refusal as a continuation of Indian patent…
Bill of Health
The FDA Patent History of Asthma Inhalers
By Erin Lynch
Pharmaceuticals The FDA Patent History of Asthma Inhalers Even though asthma takes an enormous toll on patients throughout the United States, many struggle to afford asthma medication. Published December 18, 2025 Author…
BioSlice Blog
Can a chemically synthesised medicine be authorised as a generic of a biological medicine? And who can challenge this?
By Alexander Roussanov, Libby Amos-Stone, Heba Jalil
On 23 October 2025, Advocate General (“AG”) Emiliou delivered his opinion in Case C-118/24: Laboratoires Eurogenerics and Theramex France.[1] The AG opines on three key questions regarding the use of the…
Religion Clause
FDA Approves Generic Mifepristone
The pharmaceutical company Evita Solutions announced that last month the FDA approved its generic version of the abortion pill mifepristone. NBC News reporting on the FDA action said in part:The FDA…
Inside Class Actions
Claims that Drug Manufacturer Paid PBMs to Disrupt Operation of State Generic Substitution Laws not Viable, Says Illinois Court
On June 25, an Illinois federal court dismissed an antitrust class action that alleged that branded drug manufacturer Biogen harmed competition by paying Pharmacy Benefit Managers (“PBMs”) not to promote…
Rivkin Rounds
Cigna Sues Bristol Myers Squibb Alleging Scheme to Block Generic Drug
Cigna filed a lawsuit on June 24 in Manhattan federal court accusing Bristol Myers Squibb of unlawfully blocking generic versions of its blood cancer drug, Pomalyst, from entering the market.…